# PharmaCyte Biotech, Inc.: Form 8-K, filed Aug 18, 2025

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2025-08-18
- Accepted by EDGAR: Aug 18, 2025, 13:20 ET
- Period: 2025-08-17
- Accession: 0001683168-25-006274
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316825006274/pharmacyte_8k.htm

Filed Aug 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-006274. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.